Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial. - Brody JD; Jørgensen J; Belada D; Costello R; Trněný M; Vitolo U; Lewis DJ; Karimi YH; Sureda A; André M; Wahlin BE; Lugtenburg PJ; et al. (Blood, 2025)